Effectiveness of an asthma management program for pediatric members of a large health maintenance organization.
OBJECTIVE
To assess the impact of an asthma management program on the dispensing of inhaled corticosteroids, hospitalizations, and emergency department (ED) visits on children, adolescents, and young adults.


METHODS
We used medical record and pharmacy data for the 18 months after initiation of a pilot asthma management program. Two intervention offices were matched with 2 control offices on pediatric volume, number of pediatricians or family practitioners, and specialist availability.


METHODS
Primary care offices at Kaiser Permanente Colorado, in Denver and Boulder.


METHODS
We identified 298 patients, 18 years or younger,who were listed in an asthma registry between February 1 and July 31, 1997, as having moderate or severe asthma.


METHODS
The Kaiser Permanente Colorado Asthma Care Management Program is an outpatient-based program that provides comprehensive evaluation, education, and follow-up to patients identified from an asthma registry or referred by providers.


METHODS
The proportion of patients who received more than 1 dispensing of inhaled corticosteroid during the observation period. Additional outcomes measured the proportion of patients with 1 or more hospitalizations or ED visits.


RESULTS
A significantly greater proportion of patients from the intervention group received more than 1 dispensing of inhaled corticosteroid compared with controls (relative risk [RR], 1.41; 95% confidence interval [CI], 1.08-1.72). We found no significant difference in the proportion of patients who were hospitalized (RR, 1.37; 95% CI, 0.48-3.71) or visited the ED (RR, 0.86; 95% CI, 0.49-1.40).


CONCLUSIONS
The presence of an asthma management program may improve dispensing of inhaled corticosteroids to young patients with moderate or severe asthma, as recommended by national guidelines. This type of program may not have an effect on hospitalizations or ED visits.
Lukacs
Susan L
SL
Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, USA. srl2@cdc.gov
France
Eric K
EK
Barón
Anna E
AE
Crane
Lori A
LA
D000280:Administration, Inhalation; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D001249:Asthma / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D003120:Colorado; D019468:Disease Management; D005260:Female; D006279:Health Maintenance Organizations / Q000592:standards*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D016015:Logistic Models; D008297:Male; D015999:Multivariate Analysis; D017063:Outcome Assessment, Health Care; D010865:Pilot Projects
D000305:Adrenal Cortex Hormones